Human-rhesus reassortant rotavirus vaccines: Safety and immunogenicity in adults, infants, and children

Journal of Infectious Diseases

Volumn 158, Issue 6, 1988, Pages 1261-1267

  Halsey, Neal A ^a,b,c   Anderson, Edwin L ^a,b,c   Sears, Stephen D ^a,b,c   Steinhoff, Mark ^a,b,c   Wilson, Modena ^a,b,c   Belshe, Robert B ^a,b,c   Midthun, Karen ^a,b,c   Kapiklan, Albert Z ^a,b,c   Chanock, Robert M ^a,b,c   Samorodin, Roberta ^a,b,c   Burns, Barbara ^a,b,c   Lou Clements, Mary ^a,b,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ADULT; CHILD; DRUG SAFETY; HUMAN; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; ROTAVIRUS; VACCINATION; VIRUS STRAIN;

ADULT; ANIMAL; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; HUMAN; INFANT; MACACA MULATTA; NEUTRALIZATION TESTS; ROTAVIRUS; SUPPORT, U.S. GOV'T, P.H.S.; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0024246523     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/158.6.1261     Document Type: Article

References (31)

1. Kapikian AZ, Chanock RM. Rotaviruses. In: Fields BN, Knipe DM, Chanock RM, Melnick JL, Roizman B, Shope RE, eds. Virology. New York: Raven Press, 1985:863-906
2. Estes MK, Palmer EL, Obijeski JF. Rotaviruses: A review. Curr Top Microbiol Immunol 1983;105:123-84
3. Black RE, Merson MH, Huq I, Alim ARMA, Yunus MD. Incidence and severity of rotavirus and Escherichia coli diarrhea in rural Bangladesh: Implications for vaccine development. Lancet 1983;1:141-3
4. Flores J, Nakagomi O, Nakagomi T, Glass R, Gorziglia M, Askaa J, Hoshino Y, Perez-Schael I, Kapikian AZ. The role of rotaviruses in pediatric diarrhea. Pediatric Infectious Disease 1986;5:(Suppl): S53-62
5. Institute of Medicine. Appendix O. The prospects for immunizing against rotavirus. New vaccine development. Establishing priorities. Vol I. Diseases of importance in the United States. Washington, DC: National Academy Press, 1985:410-21
6. Institute of Medicine. Appendix D-13. The prospects for immunizing against rotavirus. New vaccine development. Establishing priorities. Vol II. Diseases of importance in developing countries. Washington, DC: National Academy Press, 1986:308-18
7. De Zoysa I, Feachem RG. Interventions for the control of diarrhoeal diseases among young children: Rotavirus and cholera immunization. Bull WHO 1985;63:569-83
8. Edelman R. Perspective on the development and deployment of rotavirus vaccines. Pediatr Infect Dis J 1987;6:704-10
9. Rennels MB, Losonsky GA, Levine MM, Kapikian AZ, Fortier DN, Sutton JM, Ferra PJ, Hoffman KM. Preliminary evaluation of the efficacy of rhesus rotavirus vaccine strain MMU 18006 in young children. Pediatric Infectious Disease 1986;5:587-8
10. Kapikian AZ, Midthun K, Hoshino Y, Flores J, Wyatt RG, Glass RI, Askaa J, Nakagomi O, Nakagomi T, Chanock RM, Levine MM, Clements ML, Dolin R, Wright PF, Belshe RB, Anderson EL, Potash L. Rhesus rotavirus: A candidate vaccine for prevention of human rotavirus disease. In: Lerner RA, Chanock RM, Brown F, eds. Vaccines 85. Molecular and chemical basis of resistance to parasitic, bacterial, and viral diseases. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1985:357-67
11. Flores J, Perez-Schael I, Gonzalez M, Garcia D, Perez M, Daoud N, Cunto W, Chanock RM, Kapikian AZ. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants. Lancet 1987;1:882-4
12. Hanlon P, Hanlon L, Marsh V, Byass P, Shenton F, Hassan King M, Jobe O, Sillah H, Hayes R, M’Boge BH, Whittle HC, Greenwood BM. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1987;1:1342-5
13. Vesikari T, Isolauri E, D’Hondt E, Delem A, André FE, Zis-sis G. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1984;1:977-81
14. Vesikari T, Isolauri E, Delem A, d’Hondt E, André FE, Beards GM, Flewett TH. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr 1985;107:189-94
15. De Mol P, Zissis G, Butzler J-P, Mutwewingabo A, André FE. Failure of live, attenuated oral rotavirus vaccine [letter], Lancet 1986;2:108
16. Hoshino Y, Wyatt RG, Greenberg HB, Flores J, Kapikian AZ. Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis 1984;149:694-701
17. Matsuno S, Hasegawa A, Mukoyama A, Inouye S. A candidate for a new serotype of human rotavirus. J Virol 1985;54:623-4
18. Clark HF, Hoshino Y, Bell LM, Groff J, Hess G, Bachman P, Offit PA. Rotavirus isolate W161 representing a presumptive new human serotype J Clin Microbiol 1987;25:1757-62
19. Perez-Schael I, Gonzalez M, Daoud N, Perez M, Soto I, Garcia D, Daoud G, Kapikian AZ, Flores J. Reactogenicity and antigenicity of the rhesus rotavirus vaccine in Venezuelan children. J Infect Dis 1987;155:334-8
20. Petricciani JC, Hopps HE, Lorenz DE. Subhuman primate diploid cells: Possible substrates for production of virus vaccines. Science 1971;174:1025-7
21. Midthun K, Hoshino Y, Kapikian AZ, Chanock RM. Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4. J Clin Microbiol 1986;24:822-6
22. Midthun K, Greenberg HB, Hoshino Y, Kapikian AZ, Wyatt RG, Chanock RM. Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol 1985;53:949-54
23. Kapikian AZ, Flores J, Hoshino Y, Glass RI, Midthun K, Gorziglia M, Chanock RM. Rotavirus: The major etiologic agent of severe infantile diarrhea may be controllable by a “Jennerian” approach to vaccination. J Infect Dis 1986;153:815-22
24. Vesikari T, Kapikian AZ, Delem A, Zissis G. A comparativetrial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. J Infect Dis 1986; 153:832-9
25. Moseley SL, Escheverria P, Seriwatana J, Tirapat C, Chai-cumpa W, Sakuldaipeara T, Falkow S. Identification of enterotoxigenic Escherichia coli by colony hybridization using three enterotoxin gene probes. J. Infect Dis 1982;145:863-9
26. Nataro JP, Baldini MM, Kaper JB, Black RE, Bravo N, Levine MM. Detection of an adherence factor of enteropatho-genic Escherichia coli with a DNA probe. J Infect Dis 1985;152:560-5
27. Wyatt RG, Greenberg HB, James WD, Pittman AL, Kalica AR, Flores J, Chanock RM, Kapikian AZ. Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun 1982;37:110-5
28. Wyatt RG, James HD Jr, Pittman AL, Hoshino Y, Greenberg HB, Kalica AR, Flores J, Kapikian AZ. Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol 1983; 18:310-7
29. Chiba S, Yokoyama T, Nakata S, Morita Y, Urasawa T, Taniguchi K, Urasawa S, Nakao T. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet 1986;2:417-21
30. Losonsky GA, Vonderfecht SL, Eiden J, Wee S-B, Yolken RH. Homotypic and heterotypic antibodies for prevention of experimental rotavirus gastroenteritis. J Clin Microbiol 1986;24:1041-4
31. Vodopija I, Baklaic Z, Vlatkovic R, Bogaerts H, Delem A, Andre FE. Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain. Vaccine 1986;4:233-6